At week 12 and W24 there were nominally significant reductions in total ceramides, consistent with a reduction in inflammation, likely due to the weight loss or reduction in insulin resistance accompanying ML treatment.
← all excerpts
12436 Madelung’S Multiple Symmetric Lipomatosis: A New Indication For Leptin Pathway Activation?
1
—
—